4 results
Profiles of Antidiabetic Medications - AACE 2018 

#Antidiabetic #Medications #Profiles #SideEffects #Table #DecisionAid #Orals #DM2 #Diabetes
#SideEffects #Table ... #DecisionAid #Orals ... #DM2 #Diabetes ... #Endocrinology # ... Pharmacology #Management
Glucose-lowering medication in type 2 diabetes - Algorithm

#Diabetes #Medications #Algorithm #Pharmacology #Pharmacotherapy #Hypoglycemic #Management #Endocrinology
Diabetes #Medications ... #Algorithm #Pharmacology ... #Pharmacotherapy ... #Hypoglycemic #Management ... #Endocrinology
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
#management #algorithm ... #pharmacology # ... treatment #medications ... #table #pharmacotherapy ... #warfarin #dosing
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
-1 Agonist Dosing ... has a similar titration ... #semaglutide #Diabetes ... #Pharmacology # ... Endocrinology